Hevolution
Signal active
Investment Firm
Overview
Hevolution is a research, science, and expertise in the field of healthspan science, reshaping policy, and regulation to support healthspan science for everyone's benefit. It offers humanity a path to a health span by supporting innovation in life sciences and medicine that focuses on the biology of aging itself rather than disease.
Highlights
Founded
2021
Industry
Biotechnology
Employees
11-50
Investment
4
Lead Investment
2
Exits
undefined
Stages
Early Stage Venture
Investor Type
N/A
Location
Asia
Contact Information
Social
Profile Resume
Hevolution, established in 2021 and headquartered in Asia., specializes in Early Stage Venture investments across Financial Services, Venture Capital, Finance, Incubators, Angel Investment, Gaming, Video Games, Health Care, Robotics, Information Technology. Their recent investments include Khosla Ventures, Refactor, Italian Angels for Growth, Shanda Group, Modi Ventures. The highest investment round they participated in was $8.5B. Among their most notable exits are Khosla Ventures and Refactor. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Hevolution has made 4 investments. Their most recent investment was on Dec 01, 2023, when American Federation for Aging Research (AFAR) raised $16.0M.
investments
4
Diversity investments
1
Lead investments
2
Number of exits
undefined
Investments
4
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jul 24, 2023 | Impetus Grants | Non Profit | 10.0M |
| Dec 01, 2023 | American Federation for Aging Research (AFAR) | Biotechnology | 16.0M |
| Mar 28, 2024 | - | - | 50.0M |
| Apr 22, 2024 | - | - | 40.0M |
Exits
0
Funding Timeline
Funding rounds
4
Investors
0
Funds
0
Funding Rounds
4
Hevolution has raised 4 rounds. Their latest funding was raised on Apr 22, 2024 from a Series A - Rubedo Life Sciences round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jul 24, 2023 | Grant - Impetus Grants | - | 10.0M | - |
| Dec 01, 2023 | Grant - American Federation for Aging Research (AFAR) | - | 16.0M | - |
| Mar 28, 2024 | Series A - Aeovian Pharmaceuticals | - | 50.0M | - |
| Apr 22, 2024 | Series A - Rubedo Life Sciences | - | 40.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.